NPs Basic Information

Name
Talaromycin B
Molecular Formula C12H22O4
IUPAC Name*
(3S,4S,6R,9R)-9-ethyl-3-(hydroxymethyl)-1,7-dioxaspiro[5.5]undecan-4-ol
SMILES
CC[C@@H]1CC[C@@]2(C[C@@H]([C@H](CO2)CO)O)OC1
InChI
InChI=1S/C12H22O4/c1-2-9-3-4-12(15-7-9)5-11(14)10(6-13)8-16-12/h9-11,13-14H,2-8H2,1H3/t9-,10+,11+,12-/m1/s1
InChIKey
VDWRKBZMQNPUOB-NOOOWODRSA-N
Synonyms
Talaromycin B; (-)-Talaromycin B; 83780-27-2; BE3756MH6J; 1,7-Dioxaspiro(5.5)undecane-3-methanol, 9-ethyl-4-hydroxy-, (3S,4S,6R,9R)-; (3S,4S,6R,9R)-9-ETHYL-3-(HYDROXYMETHYL)-1,7-DIOXASPIRO[5.5]UNDECAN-4-OL; TALAROMYCIN-B; UNII-BE3756MH6J; SCHEMBL10566018; DTXSID90232636; (3R,6R,8S,9S)-3-ETHYL-9-(HYDROXYMETHYL)-5,11-DIOXASPIRO(5.5)UNDECAN-8-OL; (3S,4S,6R,9R)-9-ETHYL-4-HYDROXY-1,7-DIOXASPIRO(5.5)UNDECANE-3-METHANOL; 1,7-DIOXASPIRO(5.5)UNDECANE-3-METHANOL, 9-ETHYL-4-HYDROXY-, (3S-(3.ALPHA.,4.BETA.,6.ALPHA.(S*)))-(3S,4S,6R,9R)-9-ETHYL-4-HYDROXY-1,7-DIOXASPIRO(5.5)UNDECANE-3-METHANOL
CAS 83780-27-2
PubChem CID 158569
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic oxygen compounds
      • Class: Organooxygen compounds
        • Subclass: Ethers
          • Direct Parent: Ketals

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Loading...
Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Showing 0 to 0 of 0 entries

NPs Physi-Chem Properties

Molecular Weight: 230.3 ALogp: 1.2
HBD: 2 HBA: 4
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 58.9 Aromatic Rings: 2
Heavy Atoms: 16 QED Weighted: 0.751

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.676 MDCK Permeability: 0.00004910
Pgp-inhibitor: 0.002 Pgp-substrate: 0.665
Human Intestinal Absorption (HIA): 0.005 20% Bioavailability (F20%): 0.148
30% Bioavailability (F30%): 0.006

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.333 Plasma Protein Binding (PPB): 23.54%
Volume Distribution (VD): 1.591 Fu: 64.31%

ADMET: Metabolism

CYP1A2-inhibitor: 0.019 CYP1A2-substrate: 0.763
CYP2C19-inhibitor: 0.023 CYP2C19-substrate: 0.809
CYP2C9-inhibitor: 0.011 CYP2C9-substrate: 0.073
CYP2D6-inhibitor: 0.005 CYP2D6-substrate: 0.198
CYP3A4-inhibitor: 0.017 CYP3A4-substrate: 0.318

ADMET: Excretion

Clearance (CL): 11.509 Half-life (T1/2): 0.71

ADMET: Toxicity

hERG Blockers: 0.097 Human Hepatotoxicity (H-HT): 0.286
Drug-inuced Liver Injury (DILI): 0.048 AMES Toxicity: 0.153
Rat Oral Acute Toxicity: 0.015 Maximum Recommended Daily Dose: 0.469
Skin Sensitization: 0.948 Carcinogencity: 0.815
Eye Corrosion: 0.857 Eye Irritation: 0.988
Respiratory Toxicity: 0.355
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

*Note: the compound similarity was calculated by RDKIT.